血小板凝胶对糖尿病伤口愈合及体外抑菌作用的研究进展-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

血小板凝胶对糖尿病伤口愈合及体外抑菌作用的研究进展

Research progress on the effects of platelet gel on diabetic wound healing and in vitro antibacterial activity：a comprehensive review

ES评分 0 浏览量：170 下载量：0

全文阅读下载引用收藏

DOI	10.12208/j.ijcr.20260066
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2026, 10(2)
作者	陈明胜¹, 桂莉², 李伟², 刘师¹, 文斌¹, 徐雪飞¹,
作者单位	1 大理大学临床医学院云南大理 2 云南省第三人民医院云南昆明
摘要	糖尿病足溃疡（diabetic foot ulcers，DFUs）因高糖微环境、血管病变及免疫功能紊乱等多种因素导致愈合缓慢、易感染，临床治疗难度较高。通过从新鲜血液中提取高浓度血小板血浆，称为富血小板血浆（platelet-rich plasma，PRP），其活化后形成血小板凝胶（platelet-rich gel，PRG），因富含血小板衍生生长因子、血管内皮生长因子等多种生物活性物质，可通过促进成纤维细胞增殖、加速血管新生、调控局部炎症反应，为糖尿病伤口愈合创造良好微环境，近年来成为该领域的研究热点。本文从制备方法、临床疗效、体外抑菌及展望四个维度展开综述。综合分析显示，临床研究表明APG作为DFU的辅助治疗手段，可显著提高愈合率（部分研究显示提高39%～53%）并缩短愈合时间，尤其适用于慢性非缺血性伤口。然而，其疗效可能受制备方法、白细胞含量、血小板浓度及伤口严重程度影响。体外研究证实PRG对常见致病菌如金黄色葡萄球菌、大肠杆菌有短暂抑制作用，但对多重耐药菌效果有限。未来需开展高质量、标准化的多中心随机对照试验以明确最佳治疗方案，并探讨其与抗感染、血管重建等疗法的联合应用价值。
Abstract	Diabetic foot ulcers (DFUs) are featured by delayed healing and high susceptibility to infection as a result of multiple factors including hyperglycemic microenvironment, vascular lesions, and immune dysfunction, which render them highly challenging to manage in clinical practice. Platelet-rich plasma (PRP) refers to a plasma fraction with concentrated platelets isolated from fresh whole blood. Upon activation, PRP forms platelet-rich gel (PRG), which is abundant in various bioactive molecules such as platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF). By promoting fibroblast proliferation, accelerating angiogenesis, and modulating local inflammatory responses, PRG establishes a favorable microenvironment for diabetic wound repair, thus emerging as a research hotspot in this field in recent years. This review elaborates on the current advances from four aspects: preparation methods, clinical efficacy, in vitro antibacterial activity, and future perspectives. Comprehensive analysis demonstrates that clinical studies have verified PRG as an effective adjuvant therapy for DFUs, which can markedly elevate the wound healing rate (with some studies reporting an improvement ranging from 39% to 53%) and shorten the healing duration, especially for chronic non-ischemic wounds. However, its therapeutic effects may be affected by several factors, such as preparation protocols, leukocyte content, platelet concentration, and wound severity. In vitro studies have confirmed that PRG exerts a transient inhibitory effect on common pathogenic bacteria including Staphylococcus aureus and Escherichia coli, yet its efficacy against multidrug-resistant bacteria remains limited. In the future, it is imperative to conduct high-quality, standardized multicenter randomized controlled trials to identify the optimal therapeutic regimen, and further explore the value of its combined application with other strategies such as anti-infective therapy and vascular reconstruction.
关键词	糖尿病足溃疡；富血小板血浆；制备方法；体外抑菌
KeyWord	Diabetic foot ulcers; Platelet-rich plasma; Preparation methods; In vitro antibacterial activity
基金项目
页码	30-34

参考文献
相关文献

[1] McDermott K, Fang M, Boulton A J M, et al. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers
[J]. Diabetes Care, 2023, 46(1): 209-221.

[2] Yang S, Hu L, Zhao Y, et al. Prevalence of multidrug-resistant bacterial infections in diabetic foot ulcers: A meta-analysis
[J]. International Wound Journal, 2024, 21(4): e14864.

[3] Anitua E, Sánchez M, Nurden A T, et al. New insights into and novel applications for platelet-rich fibrin therapies
[J]. Trends in Biotechnology, 2006, 24(5): 227-234.

[4] 郭正东,程飚.离心制备富血小板血浆对其参数及活性影响的研究进展
[J].中国美容整形外科杂志,2022,33(06):381-383+387.

[5] Aghaloo T L, Moy P K, Freymiller E G. Investigation of platelet-rich plasma in rabbit cranial defects: A pilot study
[J]. Journal of Oral and Maxillofacial Surgery, 2002, 60(10): 1176-1181.

[6] 刘娟, 陈斌, 闫福华. 富血小板血浆和浓缩生长因子对人牙周膜细胞增殖和成骨分化影响的研究
[J]. 国际口腔医学杂志, 2021, 48(5): 520-527.

[7] Anitua E, Troya M, Falcon-Pérez J M, et al. Advances in platelet rich plasma-derived extracellular vesicles for regenerative medicine: a systematic-narrative review
[J]. International journal of molecular sciences, 2023, 24(17): 13043.

[8] Davies C, Miron R J. Autolougous platelet concentrates in esthetic medicine
[J]. Periodontology 2000, 2025, 97(1): 363-419.

[9] Di Martino A, Boffa A, Andriolo L, et al. Leukocyte-rich versus leukocyte-poor platelet-rich plasma for the treatment of knee osteoarthritis: a double-blind randomized trial
[J]. American Journal of Sports Medicine, 2022, 50(3): 609-617.

[10] Belk J W, Lim J J, Keeter C, et al. Patients with knee osteoarthritis who receive platelet-rich plasma or bone marrow aspirate concentrate injections have better outcomes than patients who receive hyaluronic acid: systematic review and meta-analysis
[J]. Arthroscopy: the Journal of Arthroscopic & Related Surgery, 2023, 39(7): 1714-1734.

[11] Du L, Zeng D, Hu X, et al. The efficacy of autologous platelet-rich gel and traditional Chinese medicine in diabetic foot treatment: A parallel randomized controlled clinical trial
[J]. Annals of Vascular Surgery, 2022, 87: 529-537.

[12] Clavel S, Denizot C, Boëzennec B, et al. A randomised controlled clinical study comparing the efficacy and safety of an autologous standardised leukocyte-poor platelet gel with standard care for the treatment of chronic neuropathic diabetic foot ulcers
[J]. International Wound Journal, 2025, 22(4): e70495.

[13] Sheng X, Hu L, Li T, et al. Clinical efficacy and mechanism of the combination of autologous platelet-rich gel and recombinant human acidic fibroblast growth factor in the management of refractory diabetic foot
[J]. Frontiers in Endocrinology, 2024, 15: 1374507.

[14] Li Y, Gao Y, Gao Y, et al. Autologous platelet-rich gel treatment for diabetic chronic cutaneous ulcers: A meta-analysis of randomized controlled trials
[J]. Journal of Diabetes, 2019, 11(5): 359-369.

[15] Su Y N, Li J, Feng D H, et al. Efficacy and safety of autologous platelet-rich plasma for diabetic foot ulcers: A systematic review and meta-analysis
[J]. Journal of Wound Care, 2023, 32(12): 773-786.

[16] OuYang H, Tang Y, Yang F, et al. Platelet-rich plasma for the treatment of diabetic foot ulcer: A systematic review
[J]. Frontiers in Endocrinology, 2023, 14: 1256081.

[17] 张艺, 王思雨, 杨晴, 等. 自体富血小板血浆/凝胶联合负压封闭引流术治疗糖尿病足溃疡的荟萃分析
[J]. 生物医学工程与临床, 2024, 28(3): 389-397.

[18] 王宇泽,梁浩,苏燕,等.富血小板血浆治疗糖尿病足溃疡的荟萃分析
[J].实用临床医药杂志,2025,29(11):20-25.

[19] 花鸣春, 李朝旭, 贝朝勇, 等. 自体贫白细胞富血小板血浆、富白细胞富血小板血浆治疗膝骨性关节炎疗效差异分析
[J]. 临床和实验医学杂志, 2024, 23(17): 1797-1802.

[20] 谷涌泉,冉兴无,郭连瑞,等.中国糖尿病足诊治指南
[J].中国临床医生杂志,2024,52(11):1287-1296.

[21] Li T, Ma Y, Wang M, et al. Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds
[J]. Infection and Drug Resistance, 2019, Volume 12: 297-309.

[22] Aboelsaad E, Moustafa S, Amine A, et al. Platelet-rich plasma as a potential antimicrobial agent against multidrug-resistant bacteria in diabetic foot infections
[J]. Scientific Reports, 2025, 15(1): 15145.

[23] 传丰宁. 糖尿病足溃疡患者的贫血：患病率、临床特征及预后
[D]. 重庆: 重庆医科大学, 2016.

引用本文

陈明胜, 桂莉, 李伟, 刘师, 文斌, 徐雪飞. 血小板凝胶对糖尿病伤口愈合及体外抑菌作用的研究进展 [J]. 国际临床研究杂志. 2026; 10; (2). 30 - 34.

文献评论

相关学者

相关机构